Department of Cardiovascular Disease, University of South Florida Morsani College of Medicine, South Tampa Campus (5th Floor), Two Tampa General Circle, Tampa, FL 33606, USA.
Heart Fail Clin. 2013 Oct;9(4):385-95, vii. doi: 10.1016/j.hfc.2013.06.002. Epub 2013 Jul 30.
In patients with atrial fibrillation (AF) undergoing cardiac resynchronization therapy (CRT) for heart failure, continuous monitoring of the percentage of biventricular BiV% pacing has shown that the greatest improvement and reduction in mortality occur with a BiV pacing greater than 98%. Continuous monitoring of BiV pacing has improved the CRT management of patients with AF. Continuous monitoring has generated important new questions about anticoagulant therapy, which require randomized trials. Anticoagulant therapy should probably be considered in patients who have a high risk of thromboembolism according to standard scoring systems.
在因心力衰竭而接受心脏再同步治疗（CRT）的心房颤动（AF）患者中，对双心室起搏百分比（BiV%）的连续监测表明，BiV 起搏大于 98%时可获得最大的改善和降低死亡率。BiV 起搏的连续监测改善了 AF 患者的 CRT 管理。连续监测提出了有关抗凝治疗的重要新问题，这需要进行随机试验。根据标准评分系统，对于血栓栓塞风险较高的患者，可能需要考虑抗凝治疗。
